title: Safety and efficacy study on etanercept in patients with plaque psoriasis.
authors.forename: A
authors.initials: A
authors.lastname: Costanzo
authors.forename: A
authors.initials: A
authors.lastname: Mazzotta
authors.forename: M
authors.initials: M
authors.lastname: Papoutsaki
authors.forename: S
authors.initials: S
authors.lastname: Nisticò
authors.forename: S
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept